Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Invesco S&P 500 Low Volatility ETF (SPLV) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Invesco S&P 500 Low Volatility ETFTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Invesco S&P 500 Low Volatility ETF vs Health Care Select Sector SPDR Fund — how do they compare? Invesco S&P 500 Low Volatility ETF trades at $71.97 (market cap $7.00B), while Health Care Select Sector SPDR Fund trades at $168.2 (market cap $43.11B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 6.2× Invesco S&P 500 Low Volatility ETF's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Invesco S&P 500 Low Volatility ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Invesco S&P 500 Low Volatility ETF for 123 Days and Health Care Select Sector SPDR Fund for 100 Days on average.

SPLVXLV
Market Cap
$7.00B$43.11B
Volume
1,622,5638,870,090
52-Week High
$77.97$175.68
52-Week Low
$70.30$141.95
Typical Hold Time
123 Days100 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Invesco S&P 500 Low Volatility ETF

SPLV trades at $71.22, down 0.71% with a bearish technical signal from moving averages. The ETF's sector overweights in Utilities, Real Estate, and Financials have contributed to underperformance versus the S&P 500. Recent dividend payments of $0.14 per share were distributed in July and September 2026, while technical indicators show mixed signals with neutral RSI readings but strong bearish ADX momentum.

The outlook remains challenged by sector headwinds and unappealing growth-adjusted valuation at 19.5x P/E. Key risks include continued underperformance relative to broader market and sensitivity to interest rate movements. Opportunities exist for investors seeking low-volatility exposure during market uncertainty, though near-term catalysts appear limited.

Health Care Select Sector SPDR Fund

XLV trades at $168.81, up 1.03% with a bullish technical signal from moving averages. The healthcare ETF shows strength with 61 diversified holdings and a low 0.08% expense ratio. Recent news highlights its defensive characteristics during market volatility and potential benefits from rising interest rates. Technical indicators show support at $168 with resistance at $170, while oscillators remain neutral.

XLV offers defensive exposure to healthcare with cost efficiency, though concentration in S&P 500 stocks limits global diversification. Political uncertainty and sector-specific risks like FDA approvals present challenges, but the ETF's broad diversification and historical performance during rate hikes support a constructive outlook for long-term investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SPLV
0% Buy100% Sell
Avg holding period · 123 Days
XLV
53% Buy47% Sell
Avg holding period · 100 Days

About Invesco S&P 500 Low Volatility ETF

The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the "index Provider") compiles, maintains and calculates the underlying index, which is designed to measure the performance of the 100 least volatile constituents of the S&P 500 ® Index over the past 12 months as determined by the index Provider.

Read more on SPLV →

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV →